NCT05899153

Brief Summary

This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability and response to interventions. In these studies, they will adjust the treadmill belt speeds and/or provide real-time feedback to evaluate how a child can alter their movement. The feedback will include a wearable exoskeleton that provides resistance to the ankle and audio and visual cues based on sensors that record muscle activity. This research will investigate three goals: first, to measure how children with CP adapt their walking; second, to see if either repeated training or orthopedic surgery can improve adaptation rates; and third, to determine if individual differences in adaptation relate to improvements in walking function after treatment. This research will help develop better treatments to enhance walking capacity and performance for children with CP.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
32mo left

Started Nov 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Nov 2023Jan 2029

First Submitted

Initial submission to the registry

May 24, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

November 28, 2023

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2029

Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

4.4 years

First QC Date

May 24, 2023

Last Update Submit

February 3, 2025

Conditions

Keywords

GaitRehabilitation

Outcome Measures

Primary Outcomes (6)

  • Change in Soleus Muscle Activity

    Average stance-phase magnitude of soleus muscle activity from electromyography recording measured during gait at 1-month follow-up.

    Change from baseline to intervention follow-up, assessed up to 18 months

  • Change in Peak Ankle Power

    Average peak ankle power evaluated during gait.

    Change from baseline to intervention follow-up, assessed up to 18 months

  • Change in Self-Selected Walking Speed

    Average overground walking speed.

    Change from baseline after intervention.

  • Change in Dynamic Motor Control During Walking (Walk-DMC)

    The total variance account for by one muscle synergy calculated from electromyography recordings during gait.

    Change from baseline to intervention follow-up, assessed up to 18 months

  • Change in Gait Deviation Index (GDI)

    Deviation in gait kinematics compared to nondisabled gait.

    Change from baseline to intervention follow-up, assessed up to 18 months

  • Change in Gross Motor Function Measure - 66 (GMFM-66) Parts D & E

    Assessment tool designed and evaluated to measure changes in gross motor function. Parts D \& E focus on standing, walking, jumping, and running function.

    Change from baseline to intervention follow-up, assessed up to 18 months

Study Arms (2)

Orthopedic Surgery

EXPERIMENTAL

Participants who have been scheduled for lower-extremity, multilevel orthopedic surgery will be assessed before and 9-18 months after surgery to evaluate changes in gait and adaptation rates.

Procedure: Multilevel Orthopedic Surgery

Audiovisual + Sensorimotor Biofeedback

EXPERIMENTAL

Participants will complete 12 sessions (20 minutes of walking on a treadmill) over a 6-8 week period while receiving both audiovisual and sensorimotor biofeedback. Sensorimotor biofeedback will be provided with an ankle exoskeleton that provides resistance to ankle plantarflexion during the stance phase of gait. The visual feedback will be provided on a screen with a bar showing real-time muscle activity and the audio feedback will be a sound played when they reach the target level of muscle activity from the plantarflexors.

Device: Biomotum Spark: Robotic ankle resistanceDevice: Audiovisual Biofeedback

Interventions

Robotic ankle exoskeleton that provides resistance to ankle plantarflexion.

Audiovisual + Sensorimotor Biofeedback

Electromyography recordings from the plantarflexor muscles are used to provide audio feedback via a sound that plays when muscle activity is above target and a visual bar that displays real-time muscle activity.

Audiovisual + Sensorimotor Biofeedback

Musculoskeletal surgeries to address alignment, contracture, and other lower-extremity impairments. This study does not impact surgical decision making but evaluates changes in gait before and after surgery.

Orthopedic Surgery

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of bilateral cerebral palsy that impacts both legs
  • Gross Motor Functional Classification System Level II
  • No surgery or lower-extremity injuries 12 months prior to enrollment
  • No botulinum toxin injections in prior 3 months
  • No prior selective dorsal rhizotomy surgery
  • No history of seizures or cardiac conditions that would preclude walking on a treadmill for 20 minutes
  • No current pain that hinders walking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gillette Children's

Saint Paul, Minnesota, 55101, United States

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Katherine M Steele, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Katherine M Steele, PhD

CONTACT

Alyssa Spomer, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Mechanical Engineering

Study Record Dates

First Submitted

May 24, 2023

First Posted

June 12, 2023

Study Start

November 28, 2023

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

January 1, 2029

Last Updated

February 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

De-identified participant data from gait analysis and outcome measures will be provided on a public data repository.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be made available within one year after completion of data collection.

Locations